| Authors: |
Hallberg A; Department of Pharmacy, Uppsala University, Box 580, Uppsala, 751 23, Sweden., Aakjaer M; Pharmacovigilance Research Center, Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark., Aaltonen K; INVEST Research Flagship Center, University of Turku, Turku, Finland., Andersen M; Pharmacovigilance Research Center, Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark., Pedersen E; Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway., Hajiebrahimi M; Department of Pharmacy, Uppsala University, Box 580, Uppsala, 751 23, Sweden., Nordeng H; Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway., Nyberg F; School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Samuelsen PJ; Regional Pharmacovigilance and Medicines Information Centre (RELIS), University Hospital of North Norway, Tromsø, Norway., Wettermark B; Department of Pharmacy, Uppsala University, Box 580, Uppsala, 751 23, Sweden. bjorn.wettermark@uu.se.; Pharmacy and Pharmacology Centre, Faculty of Medicine, Vilnius University, Vilnius, Lithuania. bjorn.wettermark@uu.se. |
